Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States.
- DOI
- 10.1080/14796694.2026.2705061
- Published
- 2026 Aug
- Container
- Future oncology (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/14796694.2026.2705061,
title = {Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States.},
author = {Brown JR and Munir T and Lipsky AH and Challagulla S and Campbell D and Yang K and Fu Q and Aldairy W and Williams R and Tam CS},
year = {2026},
journal = {Future oncology (London, England)},
doi = {10.1080/14796694.2026.2705061},
url = {https://doi.org/10.1080/14796694.2026.2705061}
}RIS
TY - JOUR TI - Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States. AU - Brown JR AU - Munir T AU - Lipsky AH AU - Challagulla S AU - Campbell D AU - Yang K AU - Fu Q AU - Aldairy W AU - Williams R AU - Tam CS PY - 2026 JO - Future oncology (London, England) DO - 10.1080/14796694.2026.2705061 UR - https://doi.org/10.1080/14796694.2026.2705061 ER -
APA
JR, B., T, M., AH, L., S, C., D, C., K, Y., Q, F., W, A., R, W., & CS, T. (2026). Estimated cardiac deaths associated with treating chronic lymphocytic leukemia with ibrutinib versus zanubrutinib in the United States.. Future oncology (London, England). https://doi.org/10.1080/14796694.2026.2705061
Source records
- pubmed · retrieved 2026-09-26T05:11:24.363Z